Skip to content

Efficacy of once weekly thyroxine treatment for poorly controlled hypothyroid patients

Effectiveness of lower dose once a week thyroxine therapy for thyroxine resistant hypothyroidism

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/06/008855
Enrollment
10
Registered
2017-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified Health Condition 2: null- Patients with hypothyroidism and requiring a more than ususal (1.7 mcg/kg/day) thyroxine with poor control. (TSH mor than 10mcIu/ml)

Interventions

Intervention1: Once weekly thyroxine -Dose 450 to 1300 mcg per week for 12 weeks: Directly observed hospital administered once weekly 1.7X Body Wt X 7 mcg/ week treatment for 6 weeks. Then domicilary

Sponsors

State board of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with TSH >10 mcIU/ml inspite of a Thyroxine dose more than 1.7 mcg/kg/day. 2)Those requiring a thyroxine dose more than 3mcg/kg body weight/day.

Exclusion criteria

Exclusion criteria: 1) Patients with critical Illness 2) Patients unwilling for the study. 3) Patients with known gastrointestinal malabsorptivedisrorders. 4)Patients with known structural, ischemic or rhythm disease of the heart. 5) Patients on medications known to decrease thyroxine absorption or hasten metabolism. 6) Patients accepting non-compliance to medications missing even one dose in last 6 weeks.

Design outcomes

Primary

MeasureTime frame
Decrease in TSH from baseline.Timepoint: 6 weeks and 12 weeks.

Secondary

MeasureTime frame
Percentage of patients achieving TSH less than 5 mcIU/mlTimepoint: 6 weeks, 12 weeks

Countries

India

Contacts

Public ContactAbilash Nair

Govt. Medical College Thiruvananthapuram

abhimck@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026